C3 and cystic fibrosis: Previous studies reported that alginates and especially acetylated alginates decreased C3b-mediated bacterial opsonization and therefore increased bacterial survival in clinical strains isolated from cystic fibrosis patients (17, 18), which was not confirmed in our work using the alginate hyper-producer strain CHA.